Cargando…
Development of clinical trials for non-small cell lung cancer drugs in China from 2005 to 2023
OBJECTIVE: Over the past few decades, the development of anti-cancer drugs in China has made outstanding achievements based on the support of national policies. To assess the progress of non-small cell lung cancer (NSCLC) drugs, we conducted a statistical analysis of clinical trials of drugs targeti...
Autores principales: | Jia, Wanying, Yu, Haiyan, Song, Li, Wang, Jian, Niu, Shuyu, Zang, Guojie, Liang, Mingjie, Liu, Jinwei, Na, Risu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687557/ https://www.ncbi.nlm.nih.gov/pubmed/38034540 http://dx.doi.org/10.3389/fmed.2023.1239351 |
Ejemplares similares
-
Evaluation of the Inhibitory Effects of Lactobacillus gasseri and Lactobacillus crispatus on the Adhesion of Seven Common Lower Genital Tract Infection-Causing Pathogens to Vaginal Epithelial Cells
por: He, Yuanhui, et al.
Publicado: (2020) -
Morphea: The 2023 update
por: Papara, Cristian, et al.
Publicado: (2023) -
Lichen sclerosus: The 2023 update
por: De Luca, David A., et al.
Publicado: (2023) -
Inside the April 2023 Issue
por: Galen, Benjamin T
Publicado: (2023) -
Hypoxia upregulates the expression of lncRNA H19 in non-small cell lung cancer cells and induces drug resistance
por: Li, Haiyan, et al.
Publicado: (2022)